Psilocybin Cubensis is not known to be hepatotoxic.I've heard that those mushrooms are also dangerous to the liver.
Do you have a reference for this?
Posted 20 November 2006 - 07:09 AM
Psilocybin Cubensis is not known to be hepatotoxic.I've heard that those mushrooms are also dangerous to the liver.
Posted 22 November 2006 - 01:20 AM
Posted 22 November 2006 - 07:42 AM
Regarding the initial post on this topic, correct me if i'm wrong but didn't this study show "spiritual experiences" rather than nootropic effects?
I wouldn't call being so high you don't know what's real and what's not an enchanced cognitive state.
Posted 22 November 2006 - 11:15 AM
Posted 22 November 2006 - 08:31 PM
The evidence lies in the profound lack of evidence for the opposite, as far as I'm concerned; it's generally hard to run studies on human liver enzymes for a mushroom considered the highest schedule of illegality pretty much everywhere for the past 40 years.Do you have a reference for this?
ACUTE POISONING WITH HALLUCINOGENIC PSILOCYBE MUSHROOMS IN SWITZERLAND
Kunz MW, Rauber-Lüthy Ch, Meier PJ, Kupferschmidt H. Swiss Toxicological Information Centre (STIC), Zürich and Division of Clinical Pharmacology & Toxicology, University Hospital Zürich, Switzerland
Objective: The abuse of mushrooms containing the hallucinogenic psilocybin is increasing and serious adverse effects requiring hospitalization are not uncommon. The aim of this study was to analyze the health risk of abusive "magic mushroom" ingestion between January 1995 and July 1999.
Cases and Methods: All cases recorded by the STIC between January 1995 and July 1999 were included in this retrospective study. Cases with written feedback reports of treating physicians and hospitals were analyzed with respect to type and severity of symptoms. Symptom severity was classified according to the Poisoning Severity Score (PSS) of the EAPCCT/EC/IPCS (Persson et al. J Toxicol Clin Toxicol 1998; 36:332-7).
Results: Within the analyzed period (55 months) 161 acute exposures to psilocybe mushrooms (107 males, 41 females, 13 sex unknown; median age 20y (range 14-56)) were reported to the STIC. The reported cases increased from 12 in 1995, 13 in 1996, 24 in 1997, 65 in 1998 to 47 until July in 1999. Detailed written follow-up reports were obtained in 67 cases. 26 of these 67 exposures were mixed intoxications (18 (69%) with concomitant cannabis consumption). Symptoms included hallucinations in 29 (43%) and panic attacks in 21 (31%) patients. Additional symptoms were mydriasis, gastrointestinal upset, and tachycardia. Severity was assessed as mild in 23 cases (34%), moderate in 41 cases (61%), and severe in 3 cases (4%). There were no letal intoxications. Reasons for hospitalization were marked hallucinations, hyperexcitability, panic attacks, coma and convulsions. Concomitant cannabis ingestion did not increase severity. However, concomitant opiate and ethanol ingestion induced coma (GCS 3-4) in one patient, and concomitant LSD consumption resulted in convulsions in another patient. A 19-year-old male jumped from a tree in a while having hallucinations resulting in paraplegia. Delayed reactions (flashbacks) were reported in 3 patients.
Conclusions: The data indicate that in Switzerland the number of hallucinogenic mushroom poisoning has increased during the last five years, with a sharp increase in 1998-1999. In most cases magic mushroom ingestion alone results in mild or moderate self-limited psilocybin poisoning. Severe complications can occur with the concomitant ingestion of other substances of abuse such as opioids, ethanol and/or LSD, or following self-inflicted injury due to the nature of the psychedelic effects of psilocybin.
In my lifetime I have met several users who, for a period of several months, would dose on psilocybin mushrooms several times a week. While they developed some remarkable psychological symptoms, all of them seemed perfectly healthy after their binges. Keep in mind that even OTC painkillers like APAP are very toxic to the liver, too, but are very widely used in our society.Although much of the literature supports psilocybin as having relatively low toxicity, dependence and lethality, in the last two years, cases of serious physiological intoxication by natural hallucinogenic substances have surfaces around the world. A frequent use of hallucinogenic mushrooms have demonstrated to have effects not previously classified by the use of psilocybin. Currently, clinical case and overdose studies of patients showed that psilocybin use results from arrhythmia and myocardial infarction. The indole concentrations of hallucinogenic mushrooms do not present risks of adverse central nervous system effects but also cardiac toxicity (Borowiak 1998).
The myocardial infarction in the frequent users and in cases of sever intoxication suggest the possibility of cardiac damage related to psilocybin. According to recent studies, indole alkaloids are agonists at the 5-HT receptor in the central nervous system. However, peripherally they induce a sympathomimetic stimulation that leads to tachycardia and hypertension. In the past, the use of 5-HT agonists in migraine headaches was linked to myocardial infarction due to coronary vasoconstriction. In addition, serotonin receptor agonists can cause platelet hyperaggregation and occlusion of small coronary arteries. Because psilocybin is also an agonist of 5-HT receptors, it is conclusive from these observations that the use of this drug can lead to cardiac toxicity (Borowiak 1998).
Psychedelics are generally something that will test the resilience of your inner character to a very serious extent. My theory is always: start at the lower dose, and work up, as there is always more time later if it wasn't strong enough for you. There are many books about things that can happen during the experience such as PiHKAL, TiHKAL, and the Psychedelic Experience, I would recommend checking them out before experimenting further if you ever plan to.At least I finally experienced it to have my own opinion about it. Conclusion: Not for me.
Edited by fast turtle, 22 November 2006 - 08:44 PM.
Posted 22 November 2006 - 11:04 PM
Four hours ago there was just too many messed up thoughts passing through my mind that it was overwhelming. Things like Iraq war, music, my univ studies, am I gonna be able to sleep, etc... And it was creating such an anxiety in me that I cannot explain, even looking in the mirror was whacked out. I felt intemidated by my self in a way.
Posted 23 November 2006 - 01:25 AM
Posted 23 November 2006 - 05:51 AM
The evidence lies in the profound lack of evidence for the opposite, as far as I'm concerned; it's generally hard to run studies on human liver enzymes for a mushroom considered the highest schedule of illegality pretty much everywhere for the past 40 years.Do you have a reference for this?
For instance, there are studies like this documenting psilocybe mushroom ER visits:ACUTE POISONING WITH HALLUCINOGENIC PSILOCYBE MUSHROOMS IN SWITZERLAND
Kunz MW, Rauber-Lüthy Ch, Meier PJ, Kupferschmidt H. Swiss Toxicological Information Centre (STIC), Zürich and Division of Clinical Pharmacology & Toxicology, University Hospital Zürich, Switzerland
Objective: The abuse of mushrooms containing the hallucinogenic psilocybin is increasing and serious adverse effects requiring hospitalization are not uncommon. The aim of this study was to analyze the health risk of abusive "magic mushroom" ingestion between January 1995 and July 1999.
Cases and Methods: All cases recorded by the STIC between January 1995 and July 1999 were included in this retrospective study. Cases with written feedback reports of treating physicians and hospitals were analyzed with respect to type and severity of symptoms. Symptom severity was classified according to the Poisoning Severity Score (PSS) of the EAPCCT/EC/IPCS (Persson et al. J Toxicol Clin Toxicol 1998; 36:332-7).
Results: Within the analyzed period (55 months) 161 acute exposures to psilocybe mushrooms (107 males, 41 females, 13 sex unknown; median age 20y (range 14-56)) were reported to the STIC. The reported cases increased from 12 in 1995, 13 in 1996, 24 in 1997, 65 in 1998 to 47 until July in 1999. Detailed written follow-up reports were obtained in 67 cases. 26 of these 67 exposures were mixed intoxications (18 (69%) with concomitant cannabis consumption). Symptoms included hallucinations in 29 (43%) and panic attacks in 21 (31%) patients. Additional symptoms were mydriasis, gastrointestinal upset, and tachycardia. Severity was assessed as mild in 23 cases (34%), moderate in 41 cases (61%), and severe in 3 cases (4%). There were no letal intoxications. Reasons for hospitalization were marked hallucinations, hyperexcitability, panic attacks, coma and convulsions. Concomitant cannabis ingestion did not increase severity. However, concomitant opiate and ethanol ingestion induced coma (GCS 3-4) in one patient, and concomitant LSD consumption resulted in convulsions in another patient. A 19-year-old male jumped from a tree in a while having hallucinations resulting in paraplegia. Delayed reactions (flashbacks) were reported in 3 patients.
Conclusions: The data indicate that in Switzerland the number of hallucinogenic mushroom poisoning has increased during the last five years, with a sharp increase in 1998-1999. In most cases magic mushroom ingestion alone results in mild or moderate self-limited psilocybin poisoning. Severe complications can occur with the concomitant ingestion of other substances of abuse such as opioids, ethanol and/or LSD, or following self-inflicted injury due to the nature of the psychedelic effects of psilocybin.
Traditionally, especially in the case of mushrooms, liver enzyme testing will immediately be done when someone is admitted to the ER for poisoning. The above has absolutely no mention of hepatotoxic or nephrotoxic effects in any of the subjects, and such an effect would surely be remarked about if it were to exist because it would absolutely be in the interest of those looking to study and treat psilocybin mushroom overdoses. However, there is a large amount of well documented evidence that some of the amanitas are very threatening to the liver, despite the numbers of their use in recreational users being far less than that of the psilocybin mushrooms.
I did find one article from Berkeley about cardiotoxicity:In my lifetime I have met several users who, for a period of several months, would dose on psilocybin mushrooms several times a week. While they developed some remarkable psychological symptoms, all of them seemed perfectly healthy after their binges. Keep in mind that even OTC painkillers like APAP are very toxic to the liver, too, but are very widely used in our society.Although much of the literature supports psilocybin as having relatively low toxicity, dependence and lethality, in the last two years, cases of serious physiological intoxication by natural hallucinogenic substances have surfaces around the world. A frequent use of hallucinogenic mushrooms have demonstrated to have effects not previously classified by the use of psilocybin. Currently, clinical case and overdose studies of patients showed that psilocybin use results from arrhythmia and myocardial infarction. The indole concentrations of hallucinogenic mushrooms do not present risks of adverse central nervous system effects but also cardiac toxicity (Borowiak 1998).
The myocardial infarction in the frequent users and in cases of sever intoxication suggest the possibility of cardiac damage related to psilocybin. According to recent studies, indole alkaloids are agonists at the 5-HT receptor in the central nervous system. However, peripherally they induce a sympathomimetic stimulation that leads to tachycardia and hypertension. In the past, the use of 5-HT agonists in migraine headaches was linked to myocardial infarction due to coronary vasoconstriction. In addition, serotonin receptor agonists can cause platelet hyperaggregation and occlusion of small coronary arteries. Because psilocybin is also an agonist of 5-HT receptors, it is conclusive from these observations that the use of this drug can lead to cardiac toxicity (Borowiak 1998).Psychedelics are generally something that will test the resilience of your inner character to a very serious extent. My theory is always: start at the lower dose, and work up, as there is always more time later if it wasn't strong enough for you. There are many books about things that can happen during the experience such as PiHKAL, TiHKAL, and the Psychedelic Experience, I would recommend checking them out before experimenting further if you ever plan to.At least I finally experienced it to have my own opinion about it. Conclusion: Not for me.
Edited by nootropikamil, 23 November 2006 - 06:06 AM.
Posted 23 November 2006 - 06:45 AM
Posted 25 November 2006 - 06:50 AM
Do you have a reference for this?
The somatic effects in humans were investigated first by Quetin22 in a non-blind study in healthy volunteers (n = 29, 8–12mg p.o., i.m.). The physiological changes which were noted regularly are listed in Table 1. These effects were confirmed qualitatively by another early nonblind study (n = 16, 0.11mg/kg p.o.).33 Discrete changes of RR and pulse were also confirmed in a recent double-blind placebo-controlled study (n = 8, 0.2mg/kg p.o.), as shown in Table 2.9 The effects described were barely noticeable and should be interpreted as secondary pharmacological effects, induced mainly by the sympathomimetic excitation syndrome.24 Hollister et al.25 found no significant aberrations of the aforementioned
parameters in one subject after adminstration of psilocybin for 21 consecutive days with increasing dosages (1.5 mg increased to 25mg p.o. in three doses per day). Electrolyte levels, liver toxicity tests and blood sugar levels remained unaffected.
Posted 25 November 2006 - 12:32 PM
Posted 25 November 2006 - 09:12 PM
Posted 13 December 2006 - 04:16 AM
Posted 14 December 2006 - 12:47 AM
Posted 14 December 2006 - 08:51 PM
Posted 16 December 2006 - 10:36 PM
Posted 16 December 2006 - 10:52 PM
cnorwood19
This is rich!
"And if the therapy and drugs don't work, invasive brain surgery is the only remaining option."
Hey they say we only use 10% of our brains anyway. If they took out
90% what it's gonna do? hee hee
If OCD is defined (at least partially) as "experiencing uncertainty about
completing a task" I don't see how any drug is going to totally overcome
that. Then of course the mind gravitates to the worst case scenario.
You know a person closes a house window and then as he/she turns away,
the knowledge they have closed the window is stolen from them. It wouldn't
matter, but they are leaving the house and rain might come in and.....
-Stephen
Posted 17 December 2006 - 12:58 AM
Posted 17 December 2006 - 09:02 AM
http://www.erowid.or...oms_health1.pdfThis drug is not associated with physical or psychological dependency, acute toxicity is
largely limited to possible panic and anxiety attacks and, in terms of chronic toxicity, the worst
that can happen are flashbacks. Consequently, the use of paddos (hallucinogenic
mushrooms) does not, on balance, present any risk to the health of the individual.
Posted 19 December 2006 - 10:14 AM
It makes sense to me that a psychedelic could break the normal feedback loops that cause the problem. I know sex help breaks these loops, temporarily, for some people. There must be something more powerful than their OCD to break them out of it. If we find that mushrooms can alleviate the problem, especially in severe cases, then it could be a very big step forward in giving their lives back. I can only imagine what it would be like for some of them to be actually free of their symptoms for even a short while.
Ring hydroxylation of DMT at the 4-position of the indole nucleus results in the compound psilocin
One of these people told me they had a healthy tooth pulled at the dentist without being numbed in an effort to feel something besides her chronic pain.
i think the order of psychedelic safety is pheneylethylamines, tryptamines, and then marijuana.
marijuana is known to cause anxiety and has a much higher potential for abuse than the traditional psychedelics. as far as the phen vs tryp, the phen class is safer (friendlier/easier) psychologically...i'd say dmt (a tryptamine) is probably the safest physically speaking since it is endogenous, but im not a doctor. peyote, incidentially, is in the phenyl class.
either way, abuse will screw you over, use is safe so long as u control intent, set and setting.
Posted 01 February 2007 - 04:10 AM
Edited by nootropikamil, 01 February 2007 - 04:27 AM.
Posted 28 March 2009 - 10:19 PM
Psychedelic drug use is never a good idea for someone who wishes to have optimal brain function. I prefer reality.
Posted 29 March 2009 - 02:14 AM
Posted 29 March 2009 - 09:58 AM
AFAIK, salvia divinorum (salvinorin a) doesn't have any 5-HT activity, mostly selective affinity for kappa opioid receptors (check out ibogaine for a bit of fun reading).Eating or vaporizing hashish have a few less dangers to the body... but mushrooms and pot are rather different substances with different effects on the brain, mushrooms can be better compared to lsd, dmt, salvia divinorum and mescaline...
'never is such a heavy word, man.' one view of reality is pretty ignorantly tunnel visioned, though ignorance sure is a personal choice.Psychedelic drug use is never a good idea for someone who wishes to have optimal brain function. I prefer reality.
space them between more significant changes/"checkpoints" in life, more to reflect on.They're fun for a while but after that it just gets to be the same old trip. Pot's more better.
Posted 29 March 2009 - 10:39 PM
Posted 30 March 2009 - 02:07 AM
Posted 30 March 2009 - 03:37 AM
0 members, 0 guests, 0 anonymous users